118 related articles for article (PubMed ID: 6423261)
1. The stability and antitumor activity of recycled (intravesical) mitomycin C.
Hopkins SC; Buice RG; Matheny R; Soloway MS
Cancer; 1984 May; 53(10):2063-8. PubMed ID: 6423261
[TBL] [Abstract][Full Text] [Related]
2. Detecting mitomycin C in human plasma during intravesical therapy.
Jauhiainen K
Int Urol Nephrol; 1985; 17(2):155-8. PubMed ID: 3936816
[TBL] [Abstract][Full Text] [Related]
3. [Blood and tissue levels of mitomycin C after intravesical instillation].
Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy of implanted murine bladder cancer.
Akaza H; Crabtree WN; Matheny RB; Soloway MS
Urology; 1983 Mar; 21(3):273-6. PubMed ID: 6404034
[TBL] [Abstract][Full Text] [Related]
5. Behavior and resorption of mitomycin C following multiple intravesical administrations.
van Helsdingen PJ; de Bruijn EA; Sleeboom HP; Rikken CH; Tjaden UR
J Pharm Sci; 1988 Oct; 77(10):843-6. PubMed ID: 3148709
[TBL] [Abstract][Full Text] [Related]
6. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients.
Milla P; Fiorito C; Soria F; Arpicco S; Cattel L; Gontero P
Cancer Chemother Pharmacol; 2014 Mar; 73(3):503-9. PubMed ID: 24442034
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
van Helsdingen PJ; Rikken CH; Sleeboom HP; de Bruyn EA; Tjaden UR
Urol Int; 1988; 43(1):42-6. PubMed ID: 3131943
[TBL] [Abstract][Full Text] [Related]
8. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
[TBL] [Abstract][Full Text] [Related]
9. Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial.
Svatek RS; Zhao XR; Morales EE; Jha MK; Tseng TY; Hugen CM; Hurez V; Hernandez J; Curiel TJ
Clin Cancer Res; 2015 Jan; 21(2):303-11. PubMed ID: 25424854
[TBL] [Abstract][Full Text] [Related]
10. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
Verma A; Degrado J; Hittelman AB; Wheeler MA; Kaimakliotis HZ; Weiss RM
BJU Int; 2011 Apr; 107(7):1154-61. PubMed ID: 20735383
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C reused: an in vitro cost-effectiveness study.
Carroll PR; Williams RD; Kim MJ; Dombrovskis S
J Urol; 1984 Sep; 132(3):583-6. PubMed ID: 6433045
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels during intravesical instillation of mitomycin-C.
Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
[No Abstract] [Full Text] [Related]
13. Re-use of mitomycin C in the treatment of superficial tumours of the urinary bladder: an evaluation in view of its chemical stability.
Underberg WJ; Beijnen JH
Anticancer Res; 1987; 7(4B):707-10. PubMed ID: 3118758
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.
Abbo AH; Jones DR; Masters AR; Stewart JC; Fourez L; Knapp DW
J Vet Intern Med; 2010; 24(5):1124-30. PubMed ID: 20695986
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
[TBL] [Abstract][Full Text] [Related]
16. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
17. [Effect of intravesical instillation of the antitumor chemotherapeutic agents mitomycin C and cytosine arabinoside on rat bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine].
Inoue K; Okamura T; Fukushima S; Ito N; Ohtaguro K
Gan To Kagaku Ryoho; 1987 Jan; 14(1):71-6. PubMed ID: 3099653
[TBL] [Abstract][Full Text] [Related]
18. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
19. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
Hori S; Miyake M; Tatsumi Y; Morizawa Y; Nakai Y; Onishi S; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
Oncol Rep; 2019 Mar; 41(3):1863-1874. PubMed ID: 30628699
[TBL] [Abstract][Full Text] [Related]
20. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
